For the staging of prostate cancer, the Gleason grade and prostate-specific antigen (PSA) levels were incorporated into the AJCC staging system in 2002 (6th edition) and 2010 (7th edition), respectively [5, 6]. Here, KLK3 is linked to prostate cancer.